Super V3 Investment Limited Partnership Jafco, 10% Owner at Tracon Pharmaceuticals, Inc. (TCON), sold 14,000 shares at $10.44 ($146K) on 2015-08-31, disclosed to the SEC on 2015-09-01.
Open-market sale of $146k TCON by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.44 | 6,000 | $63K | 42.9% |
| 2 | $10.41 | 8,000 | $83K | 57.1% |
| Total | $10.42 avg | 14,000 | $146K | 100% |
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |